Equity Research

Featured Research

equity development
Tristel Plc
13/10/2014
Tristel develops proprietary infection, hygiene and contamination control products used by: Human Healthcare (branded Tristel, 85% of sales); Contamination Control (Crystel, 9%), and Animal care (...
edison investment research
WANdisco plc
01/10/2014
While the wait for further major big data deals goes on, a number of deals are still expected to close this year and the company continues to make impressive progress in entrenching itself within the...
equity development
Tiziana Life Sciences PLC
30/09/2014
Tiziana Life Sciences (TILS) has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment,...